Health score, price, valuation, risk signals, and key metrics at a glance.
Syntec Optics Holdings, Inc. manufactures and supplies optics and photonics components, sub-systems, and optical systems for defense, medical, industrial, and consumer end-markets in the United States and Europe. It offers polymer-based optics; and optical assemblies, electro-optics assemblies, molded polymer and glass optic components, opto-mechanical components, nano machining, and thin films coating. The company also provides optics assembly, electro-optics assembly, design, and coating services. In addition, it is involved in the production and assembly of molded plastic optics parts including polymer and glass parts, opto-mechanicals, thin film coating, diamond turned optics, and optical systems including electro-optics assembly; and custom tooling, as well as provides engineering services. The company's products have applications in biometric, imaging, illumination, scanning, projection, blood analysis, point of care diagnosis, and fingerprint identification. Syntec Optics Holdings, Inc. was founded in 1981 and is based in Rochester, New York.
Strongest: Balance Sheet & Red Flags (21/25); weakest: Cash & Earnings Quality (5/25).
Today's multiple positioned against its own trailing range — a visual premium/discount check.
Currently below its 9-quarter median.
Currently above its 11-quarter median.
Data-driven signals worth keeping an eye on across the last 8 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF consistently trails net income (avg -0.8x) — earnings may be inflated by non-cash items or aggressive accounting.
as of June 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Currently near its 12-quarter median.
TTM revenue has contracted 17.8% — significant decline indicating deteriorating demand.
FCF turned negative in 3 of the last 8 quarters — occasional cash consumption.
Shares outstanding increased 6.8% — significant dilution, likely from stock compensation or capital raises.